je.st
news
Verastem Issued Japanese Patent On Dual mTORC1/2 And PI3K Inhibitor VS-5584
2014-02-05 07:02:35| drugdiscoveryonline News Articles
Verastem, Inc. focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, recently announced that it has been issued a patent by the Japanese Patent Office (JPO) for the company’s small molecule dual inhibitor of mTORC1/2 and PI3K VS-5584
Tags: japanese
issued
dual
patent
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||